144 related articles for article (PubMed ID: 7868386)
1. Disorazol A, an efficient inhibitor of eukaryotic organisms isolated from myxobacteria.
Irschik H; Jansen R; Gerth K; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1995 Jan; 48(1):31-5. PubMed ID: 7868386
[TBL] [Abstract][Full Text] [Related]
2. Chivosazol A, a new inhibitor of eukaryotic organisms isolated from myxobacteria.
Irschik H; Jansen R; Gerth K; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1995 Sep; 48(9):962-6. PubMed ID: 7592063
[TBL] [Abstract][Full Text] [Related]
3. The leupyrrins: a structurally unique family of secondary metabolites from the myxobacterium Sorangium cellulosum.
Bode HB; Irschik H; Wenzel SC; Reichenbach H; Müller R; Höfle G
J Nat Prod; 2003 Sep; 66(9):1203-6. PubMed ID: 14510597
[TBL] [Abstract][Full Text] [Related]
4. Gephyronic acid, a novel inhibitor of eukaryotic protein synthesis from Archangium gephyra (myxobacteria). Production, isolation, physico-chemical and biological properties, and mechanism of action.
Sasse F; Steinmetz H; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1995 Jan; 48(1):21-5. PubMed ID: 7868385
[TBL] [Abstract][Full Text] [Related]
5. Ratjadon: a new antifungal compound from Sorangium cellulosum (myxobacteria) production, physio-chemical and biological properties.
Gerth K; Schummer D; Höfle G; Irschik H; Reichenbach H
J Antibiot (Tokyo); 1995 Sep; 48(9):973-6. PubMed ID: 7592065
[TBL] [Abstract][Full Text] [Related]
6. The jerangolids: A family of new antifungal compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties of jerangolid A.
Gerth K; Washausen P; Hofle G; Irschik H; Reichenbach H
J Antibiot (Tokyo); 1996 Jan; 49(1):71-5. PubMed ID: 8609090
[TBL] [Abstract][Full Text] [Related]
7. The tartrolons, new boron-containing antibiotics from a myxobacterium, Sorangium cellulosum.
Irschik H; Schummer D; Gerth K; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1995 Jan; 48(1):26-30. PubMed ID: 7532644
[TBL] [Abstract][Full Text] [Related]
8. Pyrronazols, metabolites from the myxobacteria Nannocystis pusilla and N. exedens, are unusual chlorinated pyrone-oxazole-pyrroles.
Jansen R; Sood S; Huch V; Kunze B; Stadler M; Müller R
J Nat Prod; 2014 Feb; 77(2):320-6. PubMed ID: 24460410
[TBL] [Abstract][Full Text] [Related]
9. Pedein A and B: production, isolation, structure elucidation and biological properties of new antifungal cyclopeptides from Chondromyces pediculatus (Myxobacteria).
Kunze B; Böhlendorf B; Reichenbach H; Höfle G
J Antibiot (Tokyo); 2008 Jan; 61(1):18-26. PubMed ID: 18305355
[TBL] [Abstract][Full Text] [Related]
10. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.
Gerth K; Irschik H; Reichenbach H; Trowitzsch W
J Antibiot (Tokyo); 1980 Dec; 33(12):1474-9. PubMed ID: 6788741
[TBL] [Abstract][Full Text] [Related]
11. Production of the tubulin destabilizer disorazol in Sorangium cellulosum: biosynthetic machinery and regulatory genes.
Kopp M; Irschik H; Pradella S; Müller R
Chembiochem; 2005 Jul; 6(7):1277-86. PubMed ID: 15892181
[TBL] [Abstract][Full Text] [Related]
12. The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties.
Gerth K; Bedorf N; Irschik H; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1994 Jan; 47(1):23-31. PubMed ID: 8119858
[TBL] [Abstract][Full Text] [Related]
13. Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties.
Gerth K; Bedorf N; Höfle G; Irschik H; Reichenbach H
J Antibiot (Tokyo); 1996 Jun; 49(6):560-3. PubMed ID: 8698639
[TBL] [Abstract][Full Text] [Related]
14. Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties.
Kunze B; Jansen R; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1994 Aug; 47(8):881-6. PubMed ID: 7928674
[TBL] [Abstract][Full Text] [Related]
15. Nannochelins A, B and C, new iron-chelating compounds from Nannocystis exedens (myxobacteria). Production, isolation, physico-chemical and biological properties.
Kunze B; Trowitzsch-Kienast W; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1992 Feb; 45(2):147-50. PubMed ID: 1556005
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antifungal activity of benzo[d]oxazole-4,7-diones.
Ryu CK; Lee RY; Kim NY; Kim YH; Song AL
Bioorg Med Chem Lett; 2009 Oct; 19(20):5924-6. PubMed ID: 19733068
[TBL] [Abstract][Full Text] [Related]
17. The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria.
Irschik H; Augustiniak H; Gerth K; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1995 Aug; 48(8):787-92. PubMed ID: 7592022
[TBL] [Abstract][Full Text] [Related]
18. Ambruticin (W7783), a new antifungal antibiotic.
Ringel SM; Greenough RC; Roemer S; Connor D; Gutt AL; Blair B; Kanter G; von Strandtmann
J Antibiot (Tokyo); 1977 May; 30(5):371-5. PubMed ID: 407203
[TBL] [Abstract][Full Text] [Related]
19. Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physico-chemical and biological properties.
Sasse F; Steinmetz H; Schupp T; Petersen F; Memmert K; Hofmann H; Heusser C; Brinkmann V; von Matt P; Höfle G; Reichenbach H
J Antibiot (Tokyo); 2002 Jun; 55(6):543-51. PubMed ID: 12195959
[TBL] [Abstract][Full Text] [Related]
20. Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties.
Kunze B; Jansen R; Sasse F; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1995 Nov; 48(11):1262-6. PubMed ID: 8557566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
